COVID-19 and chronic fatigue syndrome: An endocrine perspective.
Bansal, Rashika, Gubbi, Sriram, Koch, Christian A · Journal of clinical & translational endocrinology · 2022 · DOI
Quick Summary
Some people who recover from COVID-19 experience long-lasting exhaustion and other debilitating symptoms similar to ME/CFS. This review examines how COVID-19 might affect the body's hormone systems, particularly the glands that control stress response and energy levels. The authors suggest doctors should check patients' hormone levels as part of their care plan.
Why It Matters
Understanding the role of hormone system dysfunction in post-COVID syndrome is critical because similar endocrine abnormalities have been implicated in ME/CFS pathophysiology. This connection suggests that evaluation and treatment approaches developed for post-COVID syndrome could provide insights applicable to ME/CFS patients, particularly regarding HPA axis dysfunction and its clinical management.
Observed Findings
Post-COVID-19 patients experience persistent debilitating symptoms requiring long-term rehabilitation support
HPA axis dysfunction is a potential mechanism in post-COVID-19 symptom development
Adrenal gland function abnormalities may contribute to post-COVID-19 complications
Thyroid dysfunction has been documented in post-COVID-19 patients
Multisystem involvement including endocrine complications requires comprehensive diagnostic assessment
Inferred Conclusions
Endocrinological evaluation should be incorporated as standard clinical practice in post-COVID-19 patient management
Clinicians must maintain awareness of HPA axis, adrenal, and thyroid involvement when assessing post-COVID-19 complications
Individualized, tailored rehabilitation programs should account for underlying endocrine dysfunction
Systematic assessment of occult endocrine problems may identify patients requiring additional therapeutic intervention
Remaining Questions
What is the prevalence of specific HPA axis abnormalities in post-COVID-19 versus ME/CFS populations?
What This Study Does Not Prove
This editorial does not provide original experimental data or quantitative evidence of endocrine dysfunction in COVID-19 patients. It does not establish causation between specific endocrine abnormalities and post-COVID symptoms, only reviews potential mechanistic connections. The study does not compare post-COVID syndrome directly to ME/CFS or validate whether the same endocrine pathways are involved in both conditions.